Corcept Therapeutics Inc’s filing revealed that its insider Maduck Sean unloaded Company’s shares for reported $1.01 million on Jan 02 ’25. In the deal valued at $50.39 per share,20,000 shares were sold. As a result of this transaction, Maduck Sean now holds 85,318 shares worth roughly $4.41 million.
Then, Lyon Joseph Douglas sold 5,000 shares, generating $251,950 in total proceeds. Upon selling the shares at $50.39, the insider now owns 8,759 shares.
Before that, Robb Gary Charles sold 11,000 shares. Corcept Therapeutics Inc shares valued at $555,552 were divested by the Chief Business Officer at a price of $50.50 per share. As a result of the transaction, Robb Gary Charles now holds 20,119 shares, worth roughly $1.04 million.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Monday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock jump 1.58% to $51.66. Over the last five days, the stock has lost -1.54%. Corcept Therapeutics Inc shares have risen nearly 2.52% since the year began. Nevertheless, the stocks have risen 103.87% over the past one year. While a 52-week high of $62.22 was reached on 01/02/25, a 52-week low of $20.84 was recorded on 01/02/25. SMA at 50 days reached $54.27, while 200 days put it at $38.28.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 50.38, which if violated will result in even more drops to 49.10. On the upside, there is a resistance level at 52.36. A further resistance level may holdings at 53.06. The Relative Strength Index (RSI) on the 14-day chart is 43.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.18%. Stochastics %K at 17.61% indicates the stock is a buying.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2024-12-13, dropping by -2.63 million shares to a total of 15.72 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 18.34 million shares. There was a decline of -16.73%, which implies that there is a negative sentiment for the stock.
